See also this year's filing and all EDGAR filings for this company.
PDF Report 0001274792_2018_MERRIMACK_PHARMACEUTICALS_INC.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
| info | Minor missing amount for aggregate added to remainder | industry.us_generic | {'aggregate': 'Expenses', 'missing_ratio': 0.09761323791752957, 'aggregate_val': 88017000, 'exp_sum': 97538000, 'exp_to_value': {'CostOfGoodsAndServicesSold': 0, 'SellingGeneralAndAdministrativeExpense': 28452000, 'ResearchAndDevelopmentExpense': 67314000, 'remainder_Expenses': 1772000}} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001274792')"} |
| info | Ambiguous roles for statement | input.sec.calculation_linkbase.expand_agg | {'statement': 'operations', 'valid_roles': {'100030 - Statement - Consolidated Statements of Operations and Comprehensive Income (Loss)': 21, '100040 - Statement - Consolidated Statements of Operations and Comprehensive Income (Loss)2': 2}} |
Graph
Absolute values for 0001274792, MERRIMACK PHARMACEUTICALS INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 95,046,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 6,467,000 |
| 3 | remainder_Assets | 15,813,000 |
| 4 | LiabilitiesCurrent | 19,777,000 |
| 5 | LiabilitiesNoncurrent | 56,000 |
| 6 | remainder_Liabilities | 1,209,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 28,452,000 |
| 9 | ResearchAndDevelopmentExpense | 67,314,000 |
| 10 | remainder_Expenses | -7,749,000 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 558,885,000 |
| 13 | remainder_ComprehensiveNetIncome | 1,160,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 117,326,000 |
| 1 | Liabilities | 21,042,000 |
| 2 | Expenses | 88,017,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 96,284,000 |
| 5 | NetIncome | 470,868,000 |
| 6 | ComprehensiveNetIncome | 471,448,000 |
| 7 | BaseVar | 393,215,000 |
| 8 | EconomicCapitalRatio | 9.21 |
Edgar->Model Mapping
Feature Distribution
Change over Time
